Redcliffe Labs launches women-centric diagnostic platform Femcliffe

Team L&M

Addressing the long-standing gap in women’s preventive healthcare in India, Redcliffe Labs has launched Femcliffe, the country’s first diagnostic platform built exclusively for women. Introduced as part of Redcliffe’s ‘She the Women’ campaign for Mother’s Day, the initiative serves as a timely call to prioritise women’s health. Femcliffe provides comprehensive diagnostic support across all life stages, offering preventive, curative, and specialised testing tailored to women’s evolving health needs.

Focusing on key physiological milestones, Femcliffe delivers condition-specific diagnostic packages designed to support women at every stage of life. From puberty and fertility to pregnancy, menopause, and active ageing, each package is structured to provide relevant, timely insights that help women make informed decisions about their health.

The initiative, launched in the lead-up to Mother’s Day, brings attention to a widely recognised yet often unspoken truth. In many households, the woman who keeps the family running is often the last to care for her own health. Recent studies by Redcliffe Labs revealed that one in two women admits to postponing essential health checkups, often due to caregiving duties or household responsibilities. These delays can result in the late diagnosis of common yet serious conditions such as thyroid imbalances, PCOS, anaemia, vitamin deficiencies, reproductive disorders, and early-stage metabolic diseases.

Femcliffe offers diagnostic packages to address these gaps, aligned with the distinct physiological changes women experience over time. These include hormonal assessments during adolescence, fertility and pregnancy screenings, as well as evaluations for pre- and post-menopausal health, bone density, and overall wellness. These services are available through Redcliffe’s extensive PAN India network of advanced laboratories and collection centres, with the added convenience of online booking and home sample collection.

Femcliffe also focuses on simplifying the diagnostic experience. Diagnostic reports are presented in clear, easy-to-understand formats, with actionable insights and progress tracking to support long-term health management. This approach empowers women to take a proactive role in managing their health with clarity and confidence.

Says Aditya Kandoi, CEO and founder of Redcliffe Labs, “Femcliffe is more than a diagnostic platform; it’s a promise to the millions of women who’ve always prioritised care for others but often put their health last. With Femcliffe, we’re creating a safe, supportive, she-centric, specially curated space that addresses end-to-end diagnostic requirements. It’s time we stop asking women to be strong for everyone else and start helping them stay strong for themselves.”